Actavis Bonds Fall Most in Six Weeks; Novartis Raises $4 Billion

Bonds of Actavis Plc fell the most in six weeks after the world’s second-largest generic-drugmaker by market value agreed to buy Forest Laboratories Inc. for about $25 billion. A unit of Novartis AG sold debt in two parts.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.